Polypharmacy in the Elderly: A Double-Edged Sword
暂无分享,去创建一个
[1] H. Wakabayashi,et al. Deprescribing Leads to Improved Energy Intake among Hospitalized Older Sarcopenic Adults with Polypharmacy after Stroke , 2022, Nutrients.
[2] P. Sourtzi,et al. Sarcopenia and polypharmacy among older adults: A scoping review of the literature. , 2021, Archives of gerontology and geriatrics.
[3] M. Wehling,et al. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences , 2021, European Geriatric Medicine.
[4] M. Zeegers,et al. Multimorbidity and quality of life: Systematic literature review and meta-analysis , 2019, Ageing Research Reviews.
[5] C. Meisinger,et al. The Association Between Polypharmacy and Physical Function in Older Adults: a Systematic Review , 2019, Journal of General Internal Medicine.
[6] K. Johnell,et al. An update on the clinical consequences of polypharmacy in older adults: a narrative review , 2018, Expert opinion on drug safety.
[7] I. Kunnamo,et al. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy , 2018, BMC Family Practice.
[8] D. Kuh,et al. Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study , 2018, Journal of the American Geriatrics Society.
[9] Gillian E. Caughey,et al. What is polypharmacy? A systematic review of definitions , 2017, BMC Geriatrics.
[10] Y. Shiratsuchi,et al. The relationship between polypharmacy and recovery of activities of daily living among convalescent stroke patients: A propensity score-matched analysis , 2017 .
[11] A. Majeed,et al. Current and future perspectives on the management of polypharmacy , 2017, BMC Family Practice.
[12] H. Yavuzer,et al. Is Depression a Predictive Factor for Polypharmacy in Elderly , 2016 .
[13] M. Goldstein,et al. Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review , 2014, Journal of the American Geriatrics Society.
[14] F. López-Muñoz,et al. Risk–benefit analysis of antidepressant drug treatment in the elderly , 2014, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.
[15] A. Wollny,et al. Optimizing polypharmacy among elderly hospital patients with chronic diseases—study protocol of the cluster randomized controlled POLITE-RCT trial , 2014, Implementation Science.
[16] G. Onder,et al. Physical performance measures and polypharmacy among hospitalized older adults: Results from the crime study , 2014, The journal of nutrition, health & aging.
[17] R. Sulkava,et al. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three‐year period in an elderly population , 2011, Pharmacoepidemiology and drug safety.
[18] Sandrine Andrieu,et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. , 2011, Journal of the American Medical Directors Association.
[19] P. Bytzer. Dyspepsia as an adverse effect of drugs. , 2010, Best practice & research. Clinical gastroenterology.
[20] D. Woodwell,et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. , 2010, The American journal of geriatric pharmacotherapy.
[21] M. Trabucchi,et al. Gender differences and health status in old and very old patients. , 2009, Journal of the American Medical Directors Association.
[22] J. Wyka,et al. Nutritional determination of the health status in polish elderly people from an urban environment , 2009, The journal of nutrition, health & aging.
[23] E. Hummers-Pradier,et al. Prevalence and predictors of polypharmacy among older primary care patients in Germany. , 2006, Family practice.
[24] X. Cheng,et al. Underuse of Medications for Chronic Diseases in the Oldest of Community‐Dwelling Older Frail Japanese , 2006, Journal of the American Geriatrics Society.
[25] L. V. Van Bortel,et al. PHARMACOTHERAPY OF DEPRESSION IN OLD AGE , 2005, Acta clinica Belgica.
[26] M. Tinetti,et al. The Relationship Between Number of Medications and Weight Loss or Impaired Balance in Older Adults , 2004, Journal of the American Geriatrics Society.
[27] G. Pickering. Frail elderly, nutritional status and drugs. , 2004, Archives of gerontology and geriatrics.
[28] M. Dimatteo,et al. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.
[29] F. Haaijer-Ruskamp,et al. Adverse drug reactions and polypharmacy in the elderly in general practice , 1999, European Journal of Clinical Pharmacology.
[30] E. Steinhagen-Thiessen,et al. Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.